📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Muscle overexpression of Klf15 via an AAV8-Spc5-12 construct does not provide benefits in spinal muscular atrophy mice. (2019)

First Author: Ahlskog N

Attributed to: Peptide conjugated oligonucleotides for a phase I/IIa clinical trial in Spinal Muscular Atrophy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41434-020-0146-8

PubMed Identifier: 32313099

Publication URI: http://europepmc.org/abstract/MED/32313099

Type: Journal Article/Review

Volume: 27

Parent Publication: Gene therapy

Issue: 10-11

ISSN: 0969-7128